The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

VJVirtual | Cell-free DNA liquid biopsy in lung cancer

Name: Cell-free DNA liquid biopsy in lung cancer
Uploaded: 2020-04-09T00:00:00Z
Duration: 4 min 55 s
Description: Geoffrey Oxnard, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the use of liquid biopsy for identifying resistance mutations to guide therapy decisions. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Geoffrey Oxnard • 9 Apr 2020

General Lung Cancer

Geoffrey Oxnard, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the use of liquid biopsy for identifying resistance mutations to guide therapy decisions. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).